A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Seven of Premier’s most pioneering healthcare suppliers, their products and the ways that they're helping to improve the health of communities will be celebrated.
Premier data highlights three key factors that contributed to recent drug shortages.
Value-based care can help give providers flexibility to innovate care and holds them accountable for clinical outcomes and cost of treating an entire population.
PINC AI™ Stanson developed four tools that offer an appealing alternative to streamline the burdensome prior authorization process.
Premier weighs in on the framework for the Digital Health Technologies in Drug and Biological Product Development.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Remitra® can help minimize burnout and turnover associated with overwhelming manual workloads and give staff time for more challenging work that drives healthcare forward.
CATAVERT™ stop-loss coverage solutions can help providers manage and reduce their financial risk associated with employer-sponsored health plans, improve cash flow and reduce fixed costs.